Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:

Akoya Biosciences, Inc. : This life-sciences technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.

Akoya Biosciences, Inc. Price and Consensus

Akoya Biosciences, Inc. price-consensus-chart | Akoya Biosciences, Inc. Quote

Akoya’s shares gained 11.9% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score  of A.

Akoya Biosciences, Inc. Price

Akoya Biosciences, Inc. price | Akoya Biosciences, Inc. Quote

Alpha Tau Medical Ltd. (DRTS Quick QuoteDRTS - Free Report) : This clinical-stage oncology therapeutics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.

Alpha Tau Medical Ltd. Price and Consensus

Alpha Tau Medical Ltd. price-consensus-chart | Alpha Tau Medical Ltd. Quote

Alpha Tau’s shares gained 3.6% over the last month compared with the S&P 500’s advance of 1.7%. The company possesses a Momentum Score of B.

Alpha Tau Medical Ltd. Price

Alpha Tau Medical Ltd. price | Alpha Tau Medical Ltd. Quote

Trupanion, Inc. (TRUP Quick QuoteTRUP - Free Report) : This company that engages in the business of medical insurance for cats and dogs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.

Trupanion, Inc. Price and Consensus

Trupanion, Inc. price-consensus-chart | Trupanion, Inc. Quote

Trupanion’s shares gained 8.7% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of B.

Trupanion, Inc. Price

Trupanion, Inc. price | Trupanion, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.